Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Pops Richard F
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,303,786    

Indirect Shares

   0      
Direct Value   $37,782,416    

Indirect Value

   $0      
Total Shares   1,303,786      
Total Value   $37,782,416      


Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 31,611 2005-11-23 0    Premium*  
            Alkermes Plc ALKS Director and CEO, Alke... 2024-02-08 1,179,675 2011-09-16 0    Premium*  
            Epizyme, Inc. EPZM Director 2013-05-30 60,000 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2019-01-25 32,500 0    Premium*  
* Premium Members only  

Records found :    259         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XLRN Acceleron Pharma Inc Director   –       •      –    2018-03-06 4 S $41.34 $1,553,094 D/D (37,500) 31,250 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-08 4 OE $42.76 $72,692 D/D 1,700 31,212 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-11 4 OE $42.76 $4,276 D/D 100 29,612 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-13 4 OE $42.76 $992,032 D/D 23,200 52,712 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-17 4 D $43.59 $166,993 D/D (3,831) 504,209 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-20 4 D $43.98 $168,487 D/D (3,831) 508,503 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-01 4 AS $44.01 $2,201,167 D/D (50,000) 666,352 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-08 4 AS $44.28 $2,215,775 D/D (50,000) 666,352 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-21 4 D $44.48 $170,403 D/D (3,831) 512,797 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-09-17 4 AS $44.89 $2,244,585 D/D (50,000) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-22 4 AS $45.33 $909,163 D/D (20,000) 666,352 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2016-05-16 4 D $45.64 $46,005 D/D (1,008) 30,464 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-28 4 D $45.74 $296,578 D/D (6,484) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-15 4 AS $46.38 $2,319,100 D/D (50,000) 666,352 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-10-05 4 D $46.43 $436,906 D/D (9,410) 608,962 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-06-18 4 AS $46.70 $2,336,011 D/D (50,000) 520,063 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2016-05-25 4 AS $46.72 $700,800 D/D (15,000) 15,464 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-11-02 4 AS $48.87 $2,443,410 D/D (50,000) 637,686 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-07-02 4 AS $51.68 $2,584,368 D/D (50,000) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-11-12 4 AS $52.86 $2,643,175 D/D (50,000) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-11-13 4 AS $52.88 $2,643,990 D/D (50,000) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-02-26 4 D $52.98 $249,271 D/D (4,705) 614,257 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-11-08 4 AS $53.05 $1,598,462 D/D (30,000) 608,962 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2017-05-03 4 D $53.37 $50,808 D/D (952) 29,512 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-12-10 4 AS $55.86 $2,794,139 D/D (50,000) 520,063 0 -
  259  Records found
  1   2   3   4   5   6   7   8   9  10   11      
  Page 9 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us